SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Opko Health, Inc. – ‘10-K’ for 12/31/12 – ‘EX-23.1’

On:  Monday, 3/18/13, at 4:30pm ET   ·   For:  12/31/12   ·   Accession #:  1193125-13-112598   ·   File #:  1-33528

Previous ‘10-K’:  ‘10-K’ on 3/15/12 for 12/31/11   ·   Next:  ‘10-K/A’ on 4/29/13 for 12/31/12   ·   Latest:  ‘10-K’ on 3/1/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/18/13  Opko Health, Inc.                 10-K       12/31/12  111:15M                                    Donnelley … Solutions/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.37M 
 2: EX-2.9      Plan of Acquisition, Reorganization, Arrangement,   HTML    225K 
                Liquidation or Succession                                        
 3: EX-21       Subsidiaries List                                   HTML     28K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     29K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     34K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     34K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     29K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
75: R1          Document and Entity Information                     HTML     57K 
59: R2          Consolidated Balance Sheets                         HTML    152K 
71: R3          Consolidated Balance Sheets (Parenthetical)         HTML     82K 
79: R4          Consolidated Statements of Operations               HTML    147K 
101: R5          Consolidated Statements of Comprehensive Loss       HTML     50K  
61: R6          Consolidated Statements of Shareholders' Equity     HTML    187K 
70: R7          Consolidated Statements of Shareholders' Equity     HTML     37K 
                (Parenthetical)                                                  
53: R8          Consolidated Statements of Cash Flows               HTML    188K 
43: R9          Business and Organization                           HTML     40K 
103: R10         Summary of Significant Accounting Policies          HTML     62K  
81: R11         Acquisitions, Investments, and Licenses             HTML    161K 
80: R12         Discontinued Operations                             HTML     53K 
87: R13         Composition of Certain Financial Statement          HTML    150K 
                Captions                                                         
88: R14         Debt                                                HTML     59K 
85: R15         Equity Offerings                                    HTML     39K 
89: R16         Shareholders' Equity                                HTML     60K 
72: R17         Equity-Based Compensation                           HTML     69K 
76: R18         Income Taxes                                        HTML    109K 
83: R19         Supplemental Cash Flow Information                  HTML     52K 
111: R20         Related Party Transactions                          HTML     48K  
97: R21         Employee Benefit Plans                              HTML     38K 
66: R22         Commitments and Contingencies                       HTML     38K 
82: R23         Strategic Alliances                                 HTML     30K 
68: R24         Leases                                              HTML     40K 
34: R25         Segments                                            HTML     93K 
98: R26         Fair Value Measurement                              HTML    129K 
107: R27         Derivative Contracts                                HTML     64K  
48: R28         Selected Quarterly Financial Data (Unaudited)       HTML     66K 
47: R29         Subsequent Events                                   HTML     39K 
51: R30         Summary of Significant Accounting Policies          HTML    157K 
                (Policies)                                                       
52: R31         Acquisitions, Investments, and Licenses (Tables)    HTML    142K 
54: R32         Discontinued Operations (Tables)                    HTML     48K 
22: R33         Composition of Certain Financial Statement          HTML    156K 
                Captions (Tables)                                                
95: R34         Debt (Tables)                                       HTML     56K 
64: R35         Equity Offerings (Tables)                           HTML     39K 
67: R36         Shareholders' Equity (Tables)                       HTML     40K 
38: R37         Equity-Based Compensation (Tables)                  HTML     61K 
110: R38         Income Taxes (Tables)                               HTML    106K  
15: R39         Supplemental Cash Flow Information (Tables)         HTML     49K 
56: R40         Leases (Tables)                                     HTML     35K 
100: R41         Segments (Tables)                                   HTML     84K  
36: R42         Fair Value Measurement (Tables)                     HTML    126K 
46: R43         Derivative Contracts (Tables)                       HTML     52K 
50: R44         Selected Quarterly Financial Data (Unaudited)       HTML     61K 
                (Tables)                                                         
60: R45         Summary of Significant Accounting Policies          HTML    121K 
                (Details)                                                        
21: R46         Acquisitions, Investments, and Licenses (Details)   HTML     80K 
42: R47         Acquisitions, Investments, and Licenses (Details    HTML     67K 
                1)                                                               
17: R48         Acquisitions, Investments, and Licenses (Details    HTML     58K 
                2)                                                               
99: R49         Acquisitions, Investments, and Licenses (Details    HTML     61K 
                3)                                                               
35: R50         Acquisitions, Investments, and Licenses (Details    HTML     42K 
                4)                                                               
96: R51         Acquisitions, Investments, and Licenses (Details    HTML     92K 
                5)                                                               
39: R52         Acquisitions, Investments and Licenses (Details 6)  HTML     52K 
57: R53         Acquisitions, Investments and Licenses (Details 7)  HTML     77K 
16: R54         Acquisitions, Investments, and Licenses (Details    HTML    407K 
                Textual)                                                         
19: R55         Discontinued Operations (Details)                   HTML     43K 
49: R56         Discontinued Operations (Details 1)                 HTML     48K 
26: R57         Discontinued Operations (Details Textual)           HTML     33K 
104: R58         Composition of Certain Financial Statement          HTML    192K  
                Captions (Details)                                               
63: R59         Composition of Certain Financial Statement          HTML     58K 
                Captions (Details 1)                                             
86: R60         Composition of Certain Financial Statement          HTML     44K 
                Captions (Details 2)                                             
41: R61         Debt (Details)                                      HTML     67K 
44: R62         Debt (Details Textual)                              HTML     49K 
93: R63         Equity Offerings (Details)                          HTML     54K 
90: R64         Equity Offerings (Details Textual)                  HTML     53K 
65: R65         Shareholders' Equity (Details)                      HTML     51K 
92: R66         Shareholders' Equity (Details Textual)              HTML    107K 
40: R67         Equity-Based Compensation (Details)                 HTML     50K 
69: R68         Equity-Based Compensation (Details 1)               HTML     89K 
106: R69         Equity-Based Compensation (Details 2)               HTML     50K  
18: R70         Equity-Based Compensation (Details Textual)         HTML     78K 
33: R71         Income Taxes (Details)                              HTML     75K 
58: R72         Income Taxes (Details 1)                            HTML     84K 
24: R73         Income Taxes (Details 2)                            HTML     38K 
109: R74         Income Taxes (Details 3)                            HTML     52K  
37: R75         Income Taxes (Details 4)                            HTML     37K 
28: R76         Income Taxes (Details 5)                            HTML     34K 
32: R77         Income Taxes (Details Textual)                      HTML     68K 
20: R78         Supplemental Cash Flow Information (Details)        HTML     50K 
23: R79         Related Party Transactions (Details)                HTML    246K 
77: R80         Employee Benefit Plans (Details)                    HTML     36K 
30: R81         Commitments and Contingencies (Details)             HTML     46K 
105: R82         Leases (Details)                                    HTML     55K  
55: R83         Leases (Details Textual)                            HTML     30K 
84: R84         Segments (Details)                                  HTML    101K 
91: R85         Segments (Details Textual)                          HTML     37K 
29: R86         Fair Value Measurement (Details)                    HTML     53K 
31: R87         Fair Value Measurement (Details 1)                  HTML     60K 
102: R88         Fair Value Measurement (Details 2)                  HTML     52K  
25: R89         Fair Value Measurement (Details Textual)            HTML     54K 
78: R90         Derivative Contracts (Details)                      HTML     45K 
74: R91         Derivative Contracts (Details Textual)              HTML     31K 
94: R92         Selected Quarterly Financial Data (Unaudited)       HTML     87K 
                (Details)                                                        
73: R93         Selected Quarterly Financial Data (Unaudited)       HTML     34K 
                (Details Textual)                                                
62: R94         Subsequent Events (Details)                         HTML     79K 
108: XML         IDEA XML File -- Filing Summary                      XML    169K  
45: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.46M 
 9: EX-101.INS  XBRL Instance -- opk-20121231                        XML   3.12M 
11: EX-101.CAL  XBRL Calculations -- opk-20121231_cal                XML    389K 
12: EX-101.DEF  XBRL Definitions -- opk-20121231_def                 XML   1.34M 
13: EX-101.LAB  XBRL Labels -- opk-20121231_lab                      XML   2.25M 
14: EX-101.PRE  XBRL Presentations -- opk-20121231_pre               XML   1.77M 
10: EX-101.SCH  XBRL Schema -- opk-20121231                          XSD    325K 
27: ZIP         XBRL Zipped Folder -- 0001193125-13-112598-xbrl      Zip    283K 


‘EX-23.1’   —   Consent of Experts or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-23.1  

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

  1. Registration Statement (Form S-1 No. 333-177962) of OPKO Health, Inc. and subsidiaries,

 

  2. Registration Statement (Form S-3 No. 333-172168) of OPKO Health, Inc. and subsidiaries, and

 

  3. Registration Statement (Form S-8 No. 333-144040) of OPKO Health, Inc. and subsidiaries;

of our reports dated March 18, 2013, with respect to the consolidated financial statements of OPKO Health, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of OPKO Health, Inc. and subsidiaries included in this Annual Report (Form 10-K) of OPKO Health, Inc. and subsidiaries for the year ended December 31, 2012.

/s/ Ernst & Young LLP

Certified Public Accountants

Miami, Florida

March 18, 2013


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/18/134,  8-K
For Period end:12/31/1210-K/A,  4,  5,  ARS
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/18/21  Opko Health, Inc.                 10-K       12/31/20  111:16M
 7/09/13  SEC                               UPLOAD9/18/17    1:34K  Opko Health, Inc.
 6/11/13  SEC                               UPLOAD9/18/17    1:136K Opko Health, Inc.
 5/09/13  SEC                               UPLOAD9/18/17    1:167K Opko Health, Inc.
Top
Filing Submission 0001193125-13-112598   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 11, 4:12:59.1am ET